N

N-Power Medicine

Accelerates cancer therapy development for pharma

Senior Staff Quantitative Sciences

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A PhD in Statistics or Biostatistics and at least 6 years of relevant experience in oncology clinical trials, biotechnology, and statistics.
  • At least 6 years of experience applying statistical methods to oncology patient data, including advanced analytics and high-dimensional data analysis.
  • At least 3 years as a Project Data Science Lead in a cross-functional clinical development environment.
  • At least 2 years in oncology clinical trial statistics.
  • Expert knowledge of theoretical and applied epidemiology and statistics, including inferential methods for time-to-event analysis, survival analysis, and causal inference methods.
  • Expertise in designing and analyzing externally controlled studies and hybrid controls, including propensity score methods, endpoint measurement bias correction methods, and Bayesian and frequentist methods for external patient borrowing.
  • Fundamental understanding of clinical and efficacy endpoints used in oncology development.
  • Experience collaborating with clinical, biomarker, and imaging scientists to apply statistical methods to oncology drug development.
  • Extensive experience programming in R, SAS, and/or Python.
  • Strong communication and collaboration skills, including statistical consulting and interpersonal skills.
  • Ability to work and collaborate in a fast-paced startup environment.
  • Ability to influence stakeholders and advance the use of external control arms to inform go/no-go and regulatory decisions.
  • Project management skills, including managing scope and effectively delegating to other functions, staff, contractors, and external vendors.
  • Ability to work autonomously, take initiative, learn new things, and proactively solve technical problems.

Responsibilities

  • Build expert capabilities in prospective external control arms and hybrid controls combining retrospective and prospective real-world data with single-arm and randomized controlled trials, in collaboration with Quantitative Sciences leaders.
  • Provide expertise in developing statistical methodologies to mitigate observed and unobserved selection, confounding, and measurement bias in external control and hybrid control studies using retrospective and prospective observational data.
  • Guide and mentor internal teams on novel methodologies, statistical best practices, innovative clinical trial designs, statistical inference, and reporting statistical results.
  • Support key strategic collaborations with life science partners.
  • Collaborate with Data and Technology partners to define data requirements and data collection processes that enable next-generation external control arms.
  • Lead or support research study design and end-to-end delivery, including study scoping, sample size calculations, and identifying data needs.
  • Define study design elements and approaches to bias mitigation during design and analysis.
  • Develop study protocols and statistical analysis plans.
  • Lead or support execution of analysis plans, including development of adjacent algorithms and scalable tools.
  • Lead communication of novel methodology developed during studies and co-author study-result communications in peer-reviewed publications, presentations, and health authority reports.
  • Participate in internal cross-functional discussions on data and platform strategy and workflow development.
  • Champion development of tools, algorithms, and robust pipelines to support study delivery, product offerings, data improvements, and increased efficiency, scalability, and reproducibility.

About the Company

N-Power Medicine

Accelerates cancer therapy development for pharma

N-Power Medicine focuses on oncology-related drug development services. It accelerates the creation of cancer therapies by partnering with pharmaceutical companies and research institutions, leveraging advanced technologies and innovative methods to shorten development timelines and bring effective treatments to patients faster. The company’s services are delivered through collaborations, earning revenue from service fees, research grants, and potential licensing of its proprietary technologies. Compared with competitors, it emphasizes specialized oncology expertise, active partnerships, and a workflow that combines research services with opportunities for licensing, aiming to streamline development rather than just offer generic research support. The goal is to improve patient outcomes by speeding up the availability of effective cancer treatments.

Company size
51-200
Company stage
Series B
Total funding
$32M
Headquarters
Redwood City, CA
Founded
2021

Recently Posted Jobs

Explore more opportunities at N-Power Medicine

See more jobs